Ameritas Investment Partners, Inc. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 75 filers reported holding SERES THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,119
-50.3%
8,0330.0%0.00%0.0%
Q2 2023$38,478
+24.4%
8,033
+47.2%
0.00%0.0%
Q1 2023$30,941
+7.2%
5,4570.0%0.00%0.0%
Q4 2022$28,868
-17.5%
5,4570.0%0.00%
-50.0%
Q3 2022$35,000
+94.4%
5,4570.0%0.00%
+100.0%
Q2 2022$18,000
-53.8%
5,4570.0%0.00%0.0%
Q1 2022$39,000
-13.3%
5,4570.0%0.00%
-50.0%
Q4 2021$45,000
+18.4%
5,4570.0%0.00%
+100.0%
Q3 2021$38,000
-70.8%
5,4570.0%0.00%
-80.0%
Q2 2021$130,000
+39.8%
5,457
+20.6%
0.01%
+25.0%
Q1 2021$93,000
-16.2%
4,5240.0%0.00%
-20.0%
Q4 2020$111,000
-13.3%
4,5240.0%0.01%
-16.7%
Q3 2020$128,000
+753.3%
4,524
+41.2%
0.01%
+500.0%
Q2 2020$15,000
+36.4%
3,2050.0%0.00%0.0%
Q1 2020$11,0000.0%3,2050.0%0.00%
Q4 2019$11,000
+83.3%
3,205
+130.7%
0.00%
Q3 2019$6,000
+50.0%
1,3890.0%0.00%
Q2 2019$4,000
-60.0%
1,3890.0%0.00%
Q1 2019$10,000
+66.7%
1,3890.0%0.00%
Q4 2018$6,000
-45.5%
1,3890.0%0.00%
-100.0%
Q3 2018$11,000
-8.3%
1,3890.0%0.00%0.0%
Q2 2018$12,000
+20.0%
1,3890.0%0.00%
Q1 2018$10,000
-28.6%
1,3890.0%0.00%
-100.0%
Q4 2017$14,000
-26.3%
1,3890.0%0.00%0.0%
Q3 2017$19,000
+18.8%
1,3890.0%0.00%0.0%
Q2 2017$16,0000.0%1,3890.0%0.00%0.0%
Q1 2017$16,0001,3890.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 12,682,876$125,560,00040.85%
ARK Investment Management 492,064$4,871,0001.77%
Artal Group S.A. 700,000$6,930,0000.15%
Portolan Capital Management 111,054$1,099,0000.15%
Rock Springs Capital Management LP 220,000$2,178,0000.15%
CQS Cayman LP 162,000$1,604,0000.13%
Opus Point Partners Management, LLC 14,000$139,0000.11%
HAMILTON LANE ADVISORS LLC 14,883$147,0000.10%
Geduld E E 15,000$149,0000.08%
Virtus ETF Advisers LLC 28,148$279,0000.08%
View complete list of SERES THERAPEUTICS INC shareholders